Vitamin D confers protection to motoneurons and is a prognostic factor of amyotrophic lateral sclerosis

[1]  C. Karam,et al.  Vitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis , 2013, Journal of Clinical Neuroscience.

[2]  P. Caroni,et al.  Neuroprotection through Excitability and mTOR Required in ALS Motoneurons to Delay Disease and Extend Survival , 2013, Neuron.

[3]  B. Pettmann,et al.  Death Receptors in the Selective Degeneration of Motoneurons in Amyotrophic Lateral Sclerosis , 2013, Journal of neurodegenerative diseases.

[4]  S. Abrams,et al.  Vitamin D: effects on childhood health and disease , 2013, Nature Reviews Endocrinology.

[5]  M. Hamadeh,et al.  Vitamin D3 at 50x AI Attenuates the Decline in Paw Grip Endurance, but Not Disease Outcomes, in the G93A Mouse Model of ALS, and Is Toxic in Females , 2013, PloS one.

[6]  Cynthia Balion,et al.  Vitamin D, cognition, and dementia , 2012, Neurology.

[7]  L. Launer,et al.  Low Dietary Vitamin D Predicts 34-Year Incident Stroke: The Honolulu Heart Program , 2012, Stroke.

[8]  C. McCulloch,et al.  Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis , 2012, Annals of neurology.

[9]  M. Hamadeh,et al.  Dietary Vitamin D3 Supplementation at 10× the Adequate Intake Improves Functional Capacity in the G93A Transgenic Mouse Model of ALS, a Pilot Study , 2012, CNS neuroscience & therapeutics.

[10]  B. Pettmann,et al.  Reduced Calreticulin Levels Link Endoplasmic Reticulum Stress and Fas-Triggered Cell Death in Motoneurons Vulnerable to ALS , 2012, The Journal of Neuroscience.

[11]  Kerry Jones,et al.  Vitamin D and cognitive function , 2012, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[12]  W. März,et al.  Vitamin D Levels Predict All-Cause and Cardiovascular Disease Mortality in Subjects With the Metabolic Syndrome , 2012, Diabetes Care.

[13]  M. Urashima,et al.  25‐hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[14]  M. Hamadeh,et al.  Vitamin D3 Deficiency Differentially Affects Functional and Disease Outcomes in the G93A Mouse Model of Amyotrophic Lateral Sclerosis , 2011, PloS one.

[15]  Matthew C. Kiernan,et al.  Clinical diagnosis and management of amyotrophic lateral sclerosis , 2011, Nature Reviews Neurology.

[16]  Martin R. Turner,et al.  Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations , 2011, Nature Reviews Neurology.

[17]  S. Paganoni,et al.  Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis , 2011, Muscle & nerve.

[18]  R. Oppenheim,et al.  Motor neuron trophic factors: Therapeutic use in ALS? , 2011, Brain Research Reviews.

[19]  E. Hyppönen,et al.  Vitamin D status has a linear association with seasonal infections and lung function in British adults , 2011, British Journal of Nutrition.

[20]  C. Karam,et al.  Can vitamin D delay the progression of ALS? , 2011, Medical hypotheses.

[21]  B. Pettmann,et al.  IFNγ triggers a LIGHT-dependent selective death of motoneurons contributing to the non-cell-autonomous effects of mutant SOD1 , 2011, Cell Death and Differentiation.

[22]  J. Kassubek,et al.  Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis , 2011, Journal of Neurology.

[23]  B. Pettmann,et al.  Enhanced neuronal Met signalling levels in ALS mice delay disease onset , 2011, Cell Death and Disease.

[24]  M. Hernán,et al.  Smoking and the risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[25]  C. Armon.  Smoking may be considered an established risk factor for sporadic ALS , 2009, Neurology.

[26]  E. Beghi,et al.  Prognostic factors in ALS: A critical review , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[27]  B. Mohammadi,et al.  ALSFRS-R score and its ratio: A useful predictor for ALS-progression , 2008, Journal of the Neurological Sciences.

[28]  F. Belardetti,et al.  Linking calcium-channel isoforms to potential therapies. , 2008, Current opinion in investigational drugs.

[29]  V. Meininger,et al.  Dyslipidemia is a protective factor in amyotrophic lateral sclerosis , 2008, Neurology.

[30]  N. Mercuri,et al.  Altered calcium homeostasis in motor neurons following AMPA receptor but not voltage-dependent calcium channels’ activation in a genetic model of amyotrophic lateral sclerosis , 2007, Neurobiology of Disease.

[31]  N. Porter,et al.  Chronic 1α,25-(OH)2vitamin D3 treatment reduces Ca2+-mediated hippocampal biomarkers of aging , 2006 .

[32]  B. Pettmann,et al.  Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[33]  T. Hanafusa,et al.  Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS , 2006, Neurology.

[34]  J. Valmier,et al.  K+ current regulates calcium‐activated chloride current‐induced afterdepolarization in axotomized sensory neurons , 2005, The European journal of neuroscience.

[35]  Jian Q. Feng,et al.  Critical Role of Calbindin-D28k in Calcium Homeostasis Revealed by Mice Lacking Both Vitamin D Receptor and Calbindin-D28k* , 2004, Journal of Biological Chemistry.

[36]  F. Hu,et al.  Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y. , 2004, The American journal of clinical nutrition.

[37]  A. Kalueff,et al.  Impaired motor performance in mice lacking neurosteroid vitamin D receptors , 2004, Brain Research Bulletin.

[38]  D. Eyles,et al.  1,25-Dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons , 2003, Neuroscience Letters.

[39]  H. Wichterle,et al.  Directed Differentiation of Embryonic Stem Cells into Motor Neurons , 2002, Cell.

[40]  Philip W. Landfield,et al.  Vitamin D Hormone Confers Neuroprotection in Parallel with Downregulation of L-Type Calcium Channel Expression in Hippocampal Neurons , 2001, The Journal of Neuroscience.

[41]  O. Hardiman,et al.  Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study. , 2000, Archives of neurology.

[42]  B. Pettmann,et al.  Programmed Cell Death of Embryonic Motoneurons Triggered through the FAS Death Receptor , 1999, The Journal of cell biology.

[43]  C. Paillart,et al.  Specific distribution of sodium channels in axons of rat embryo spinal motoneurones , 1999, The Journal of physiology.

[44]  S. Appel,et al.  1α, 25 dihydroxyvitamin D3‐dependent up‐regulation of calcium‐binding proteins in motoneuron cells , 1998 .

[45]  L. Colom,et al.  Expression of calbindin-D28K in motoneuron hybrid cells after retroviral infection with calbindin-D28K cDNA prevents amyotrophic lateral sclerosis IgG-mediated cytotoxicity. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[46]  K. Haglid,et al.  Parvalbumin increases in the caudate putamen of rats with vitamin D hypervitaminosis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[47]  N. Porter,et al.  Chronic 1alpha,25-(OH)2 vitamin D3 treatment reduces Ca2+ -mediated hippocampal biomarkers of aging. , 2006, Cell calcium.

[48]  B. Pettmann,et al.  Cardiotrophin‐1 requires LIFRβ to promote survival of mouse motoneurons purified by a novel technique , 1999, Journal of neuroscience research.

[49]  H. DeLuca,et al.  Molecular biology of vitamin D action. , 1994, Vitamins and hormones.